Adeolu Banjoko | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Adeolu Banjoko
Researcher Adeolu Banjoko
Affiliation University of Toronto Department of Obstetrics and Gynaecology
Country Canada
Scopus ID 57216301597
Documents 12
Citations 242
h-index 6
Subject Area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0000-0001-6849-0059

Adeolu Banjoko
University of Toronto Department of Obstetrics and Gynaecology


Adeolu Banjoko
is a researcher affiliated with the University of Toronto Department of Obstetrics and Gynaecology, Canada, whose scholarly work contributes to the advancement of medicine and health sciences. Based on bibliometric indicators available through major academic databases, the researcher has established a measurable impact through publications, citations, and interdisciplinary engagement within contemporary biomedical research environments.[1]

Abstract

This article presents an academic overview of Adeolu Banjoko and examines the scholarly indicators that support consideration for the Innovative Research Award. The review summarizes institutional affiliation, bibliometric performance, research productivity, and academic influence within medicine and health sciences. The assessment adopts a neutral encyclopedic approach and highlights measurable indicators of scientific engagement and contribution to the broader research community.[1]

Keywords

Innovative Research Award; Adeolu Banjoko; University of Toronto; Medicine and Health Sciences; Scientific Publications; Citation Analysis; Research Metrics; Academic Excellence; Scopus Author Profile; Scholarly Impact.

Introduction

Recognition through academic awards often reflects sustained scholarly activity, contribution to knowledge generation, and evidence of influence through publication and citation metrics. Contemporary evaluation frameworks employ bibliometric indicators together with qualitative assessments of originality, collaboration, and relevance to societal challenges.[3]

Research Profile

  • Scopus Documents: 12
  • Total Citations: 242
  • h-index: 6

The available bibliometric indicators suggest a developing and impactful research profile characterized by peer-reviewed publications and measurable citation performance. These indicators are commonly used to evaluate scientific productivity and the dissemination of research findings across the academic community.[1]

Research Contributions

The scholarly contributions of Adeolu Banjoko are situated within the field of medicine and health sciences and contribute to ongoing developments in clinical and biomedical research. The researcher has participated in studies that expand scientific understanding and support evidence-based approaches to healthcare and medical practice.[4]

Publications

The researcher’s publication record consists of twelve indexed documents and demonstrates continuing engagement with scientific communication and scholarly dissemination. Publication activity remains one of the primary indicators of academic productivity and contributes significantly to visibility and influence within a discipline.[1]

Research Impact

Citation metrics indicate that the published work of Adeolu Banjoko has received notable scholarly attention, accumulating 242 citations and achieving an h-index of 6. These indicators suggest that multiple publications have influenced subsequent research and contributed to continuing scientific discussions within relevant fields.[1]

Award Suitability

The profile of Adeolu Banjoko aligns with several criteria commonly associated with the Innovative Research Award, including demonstrated publication activity, measurable citation impact, sustained scholarly engagement, and contributions to the advancement of medicine and health sciences.[2]

Conclusion

Adeolu Banjoko represents a researcher whose academic profile demonstrates meaningful participation in medicine and health sciences research. Bibliometric indicators, institutional affiliation, and publication performance collectively support recognition within professional academic contexts. The profile presented in this article provides an evidence-based overview relevant to consideration for the Innovative Research Award and highlights the continuing importance of scholarly contribution to scientific advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Adeolu Banjoko, Author ID 57216301597. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216301597
  2. International Research Hypothesis. (n.d.). International Research Hypothesis Excellence Award.
    https://researchhypothesis.com/
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569-16572.
    https://doi.org/10.1073/pnas.0507655102
  4. ORCID. (n.d.). ORCID profile: Adeolu Banjoko.
    https://orcid.org/0000-0001-6849-0059

Kanokkarn Sunkonkit | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Kanokkarn Sunkonkit
Chiang Mai University Hospital
Kanokkarn Sunkonkit
Affiliation Chiang Mai University Hospital
Country Thailand
Scopus ID 57200528072
Documents 33
Citations 158
h-index 3
Subject Area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0000-0003-2725-4636

Kanokkarn Sunkonkit is a researcher affiliated with Chiang Mai University Hospital, Thailand, whose scholarly activities are associated with the field of Medicine and Health Sciences. Through peer-reviewed publications, clinical research participation, and contributions to evidence-based medical knowledge, the researcher has established a measurable academic presence reflected through publication output, citation activity, and international research visibility. The academic profile demonstrates sustained engagement with healthcare-related investigations and scholarly dissemination within recognized scientific platforms.[1][2]

Abstract

This academic recognition article presents a structured overview of the research profile of Kanokkarn Sunkonkit. The assessment considers scholarly productivity, publication record, citation performance, institutional affiliation, and engagement within the broader field of Medicine and Health Sciences. Available bibliometric indicators demonstrate an established record of scientific communication and contribution to healthcare-related research. These indicators provide a basis for evaluating suitability for recognition through the Innovative Research Award and the International Research Hypothesis Excellence Award framework.[1][3]

Keywords

  • Medicine and Health Sciences
  • Clinical Research
  • Scientific Publications
  • Research Impact
  • Citation Analysis
  • Academic Recognition
  • Healthcare Innovation
  • Evidence-Based Medicine

Introduction

Research excellence in medicine is commonly evaluated through a combination of publication productivity, citation influence, methodological rigor, and contribution to healthcare advancement. Researchers affiliated with major academic medical institutions play a significant role in translating scientific evidence into clinical practice and improving patient outcomes. Kanokkarn Sunkonkit’s scholarly profile reflects participation in this broader scientific mission through contributions documented in indexed academic literature.[1][3]

Research Profile

Kanokkarn Sunkonkit is affiliated with Chiang Mai University Hospital, a recognized academic healthcare institution in Thailand. The researcher’s documented academic record includes 33 indexed publications, 158 citations, and an h-index of 3. These metrics provide evidence of sustained scholarly activity and visibility within the medical research community.[1]

Research Contributions

The research contributions associated with Kanokkarn Sunkonkit are situated within the broader domain of Medicine and Health Sciences. Scholarly activities include participation in clinical investigations, publication of research findings, collaboration with academic and healthcare professionals, and dissemination of evidence-based knowledge. Such contributions support ongoing scientific advancement and healthcare improvement initiatives.[1][4]

Publications

The publication portfolio associated with the researcher consists of 33 indexed documents. Publications contribute to the dissemination of scientific findings and form an essential component of academic evaluation. Indexed research outputs increase accessibility, encourage scholarly discussion, and facilitate citation by other investigators.[1]

Research Impact

Research impact is frequently assessed through citation performance and scholarly influence. The citation count of 158 indicates that published works have been referenced within subsequent academic literature. Citation activity serves as one indicator of knowledge dissemination and engagement within the scientific community, although impact may also include educational, clinical, and societal outcomes.[1][5]

Award Suitability

Based on the available scholarly indicators, Kanokkarn Sunkonkit demonstrates characteristics commonly considered during evaluations for academic recognition programs. These characteristics include peer-reviewed publication activity, citation impact, institutional affiliation with a recognized medical center, and participation in the advancement of healthcare-related research. Such attributes align with the objectives of the Innovative Research Award and the International Research Hypothesis Excellence Award, which seek to recognize meaningful contributions to scientific inquiry and knowledge dissemination.[3][4]

Conclusion

Kanokkarn Sunkonkit maintains an academic profile characterized by indexed publications, documented citation activity, and affiliation with Chiang Mai University Hospital. The available bibliometric indicators suggest ongoing participation in the generation and dissemination of medical knowledge. Within the context of research recognition programs, the researcher represents a scholarly contributor whose work supports continued advancement in Medicine and Health Sciences.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Kanokkarn Sunkonkit, Author ID 57200528072. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57200528072
  2. ORCID. (n.d.). ORCID profile record for Kanokkarn Sunkonkit.
    https://orcid.org/0000-0003-2725-4636
  3. International Research Hypothesis Excellence Award. (n.d.). Award objectives and academic recognition framework.
    https://researchhypothesis.com/
  4. Admission Red Blood Cell Distribution Width and Mean Platelet Volume as Predictors of Mortality in the Pediatric Intensive Care Unit: A Five-Year Single-Center Retrospective Study.
    https://pubmed.ncbi.nlm.nih.gov/40507603/
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102

Xhevdet Krasniqi | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Xhevdet Krasniqi
Medical Faculty, University of Prishtina “Hasan Prishtina”

Xhevdet Krasniqi
Affiliation Medical Faculty, University of Prishtina “Hasan Prishtina”
Country Albania
Scopus ID 36113661500
Documents 37
Citations 76
h-index 5
Subject Area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0009-0003-5721-4907

Xhevdet Krasniqi, affiliated with the Medical Faculty of the University of Prishtina “Hasan Prishtina”, has developed a publication record within the field of Medicine and Health Sciences, demonstrating sustained engagement in academic research and scholarly dissemination.[1] His documented scientific output, citation profile, and participation in internationally indexed research platforms provide measurable indicators of research activity and academic contribution.[2]

Abstract

This article presents a scholarly overview of Xhevdet Krasniqi and evaluates the suitability of his academic profile for recognition through the Innovative Research Award. The assessment considers publication activity, citation performance, research visibility, institutional affiliation, and contributions within Medicine and Health Sciences. Available bibliometric indicators suggest an active research profile supported by peer-reviewed publications and international indexing systems.[1][2]

Keywords

Medicine and Health Sciences; Academic Research; Scientific Publications; Citation Analysis; Scopus Author Profile; Research Excellence; Scholarly Impact; University of Prishtina; Innovation in Healthcare; Research Assessment.

Introduction

Research awards serve an important role in acknowledging scientific achievements and promoting excellence across academic disciplines. Recognition programs frequently evaluate publication productivity, citation performance, collaborative engagement, and contributions to advancing knowledge within a specific field.[3] In this context, Xhevdet Krasniqi’s scholarly activities are examined through publicly available academic indicators and professional research profiles.[2]

Research Profile

Xhevdet Krasniqi is affiliated with the Medical Faculty of the University of Prishtina “Hasan Prishtina”. His scholarly record includes publications indexed through international databases and reflected in author profiling systems that support research visibility and citation tracking.[1]

Research Contributions

Research contributions are generally evaluated according to originality, methodological rigor, dissemination, and influence on subsequent scientific work. Based on available bibliometric indicators, Krasniqi has participated in research efforts that contribute to the broader development of medical knowledge and scientific discourse.[1]

Publications

The researcher’s publication portfolio includes 37 indexed documents according to available bibliometric records.[1] Publication activity represents a fundamental indicator of scholarly productivity and serves as a basis for evaluating research visibility and impact.

Research Impact

Bibliometric indicators provide a quantitative perspective on scholarly influence. Available records indicate 76 citations and an h-index of 5, reflecting measurable engagement with the researcher’s published work within the academic community.[1] Although citation metrics do not fully capture research quality, they remain widely used indicators in academic evaluation frameworks.[3]

Award Suitability

The profile of Xhevdet Krasniqi demonstrates several characteristics commonly considered in research award evaluations, including documented publication output, citation visibility, recognized researcher identifiers, and engagement within Medicine and Health Sciences.[1][2] These indicators support consideration for recognition programs that emphasize innovation, scholarly productivity, and contributions to scientific advancement.

Conclusion

Xhevdet Krasniqi’s academic profile reflects sustained participation in scientific research within Medicine and Health Sciences. Through indexed publications, citation activity, and engagement with international scholarly identification systems, the researcher demonstrates characteristics associated with academic productivity and research visibility. Based on the available evidence, the profile presents a reasonable foundation for consideration within the framework of the Innovative Research Award.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Xhevdet Krasniqi, Author ID 36113661500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36113661500
  2. ORCID. (n.d.). ORCID record for Xhevdet Krasniqi.
    https://orcid.org/0009-0003-5721-4907
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102
  4. Google Scholar. (n.d.). Scholar profile of Xhevdet Krasniqi.
    https://scholar.google.com/citations?user=wPle3w0AAAAJ&hl=en&oi=sra
  5. International Research Hypothesis Excellence Award. (n.d.). Award program information and evaluation framework.
    https://researchhypothesis.com/

Valeria Herdea | Medicine and Health Sciences | Cross-disciplinary Excellence Award

Dr. Valeria Herdea | Medicine and Health Sciences | Cross-disciplinary Excellence Award

Dr. Valeria Herdea | Medicine and Health Sciences | Senior Consultant Family Medicine at George Emil Palade University of Medicine | Romania

Dr. Valeria Herdea is a dedicated medical academic and researcher specializing in pediatrics, with a strong focus on advancing child health through evidence-based research and responsible medical communication. She is affiliated with the George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where her education and advanced academic training have provided a solid foundation in clinical pediatrics, public health, and research methodology. Her professional experience includes active involvement in academic research, scholarly writing, and collaborative projects that address critical issues in pediatric care, particularly the influence of medical information on parental decision-making and child health outcomes. Dr. Valeria Herdea’s research interests center on pediatric preventive medicine, parental health behavior, pediatric public health, and the ethical dissemination of medical information. Dr. Valeria Herdea has authored 9 documents, received 105 citations, and attained a 4 h-index, underscoring her growing scholarly impact and visibility within the international research community.

Citation Metrics (Scopus)

150

120

90

60

30

0

Citations
105

Documents
9

h-index
4

🟦 Citations         🟥 Documents      🟩 h-index

View Scopus Profile

Featured Publications

Assessing the Effects of Medical Information on Parental Self-Medication Behaviors for Children’s Health: A Comparative Analysis
– Medicina (Lithuania), Open Access

Citations: 1

Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Dr. Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Dr. Natalya Semenova | Medicine and Health Sciences | Chief Researcher at Scientific Сentre for Family Health and Human Reproduction Problem | Russia 

Dr. Natalya Semenova is a highly accomplished female biomedical scientist and chief researcher recognized for her significant contributions to pathological physiology, reproductive health, and aging research. She holds a Ph.D. in Biological Sciences and has developed a strong academic foundation through advanced training in experimental biology, human reproduction, and translational medical science at leading scientific institutions. Dr. Natalya Semenova has built an extensive professional career at a federal-level public scientific research center, where she has led and contributed to numerous multidisciplinary research initiatives focused on women’s health, endocrine disorders, microbiome regulation, oxidative stress, and age-related diseases. Her professional experience reflects deep expertise in designing experimental studies, clinical-biological data interpretation, biomarker analysis, and the development of pathogenetically grounded therapeutic and preventive strategies. In the middle of her academic career profile, Dr. Natalya Semenova has authored 156 documents, received 685 citations, and achieved a 12 h-index, demonstrating consistent research productivity and measurable scholarly impact within the international scientific community.

Citation Metrics (Scopus)

1000

800

600

400

200

0

Citations
685

Documents
156

h-index
12

🟦 Citations     🟥 Documents    🟩 h-index

View Scopus Profile

Featured Publications

Optimal Algorithm for Gut Microbiota Differentiation: A Pilot Study of Adolescents with Different Body Weights
– Frontiers in Bioscience (Scholar Edition)
Phosphatidylethanol 16:0/18:1PEth as a Biomarker of Alcohol Consumption during Pregnancy
– Bulletin of Experimental Biology and Medicine
Histostructure of the Hippocampus in Male and Female Wistar Rats with Diet-Induced Visceral Obesity and after Diet Correction
– Bulletin of Experimental Biology and Medicine
Pregnancy and Alcohol: Parameters of Endogenous Intoxication Depending on Blood Phosphatidylethanol Levels
– Human Ecology
Comparative Assessment of the Gut Microbiome by Microbiological and Molecular-Genetic Methods in Sleep Disorders
– Clinical Laboratory Diagnostics

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | MD at Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished academic physician and internationally recognized expert in breast imaging and diagnostic radiology, known for her leadership in integrating advanced imaging technologies and artificial intelligence into clinical cancer care. She received her undergraduate education at Brown University with an academic focus on biomedical ethics, followed by her medical degree from Yale University School of Medicine, where she developed a strong foundation in clinical medicine and research ethics. Dr. Laurie Margolies completed rigorous postgraduate training in internal medicine, diagnostic radiology, and advanced cross-sectional imaging, equipping her with comprehensive expertise across mammography, ultrasound, MRI, and tomosynthesis. Professionally, Dr. Laurie Margolies has held progressive academic appointments culminating in a full professorship in diagnostic, molecular, and interventional radiology at a leading academic medical center, while simultaneously serving in senior health-system leadership roles including Vice Chair and System Chief for Breast Imaging.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations2177

i10index92

h-index19

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Performance of an Artificial Intelligence Support System on Screening Mammography Cases Proceeding to Stereotactic Biopsy
Cancers (Open Access)
The Tyrer-Cuzick Risk Model: Is It Effective for All Races?
Clinical Imaging
Patient Perception of Artificial Intelligence in Breast Imaging: A Pilot Survey Study
Clinical Imaging
Suspicion for Sarcoma: Clinical Presentation, Multi-Modality Imaging Evaluation, and Ultrasound Artificial Intelligence-Based Decision Support
Cancers (Open Access)
Breast Lymphoma: Imaging Features, Clinical Presentation, and Ultrasound Artificial Intelligence Decision Support
Clinical Imaging
Artificial Intelligence for Assessment of Digital Mammography Positioning Reveals Persistent Challenges
Journal of Breast Imaging
Breast Arterial Calcifications on Mammography: A Review of the Literature
Review Article
Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: A Pilot Study
Journal of Racial and Ethnic Health Disparities
Low-Dose Chest CT: Participating in the Rise of Breast Density Awareness
Journal of Women’s Health

Peng-Sheng Zheng | Medicine and Health Sciences | Research Excellence Award

Prof. Peng-Sheng Zheng | Medicine and Health Sciences | Research Excellence Award

Prof. Peng-Sheng Zheng | Medicine and Health Sciences | Professor at Xi’an Jiaotong University | China

Prof. Peng-Sheng Zheng is a distinguished Professor at Xi’an Jiaotong University and an internationally recognized physician-scientist whose career seamlessly integrates advanced medical training, translational research excellence, and global academic leadership. Prof. Peng-Sheng Zheng earned dual M.D./Ph.D. degrees from Bethune Medical University in China and Saga Medical University in Japan, establishing a strong interdisciplinary foundation in clinical medicine and biomedical research. Following doctoral training, Prof. Peng-Sheng Zheng completed prestigious postdoctoral fellowships at Memorial University of Newfoundland in Canada, the U.S. National Institutes of Health (NIH), and the University of Toronto, where he refined expertise in molecular pathology, reproductive immunology, and cancer biology. Prof. Peng-Sheng Zheng has since built an influential academic career marked by sustained research productivity, mentoring, and international collaboration.

Citation Metrics (Scopus)

4000

3000

2000

1000

500

0

Citations2773

i10index85

h-index 31

🟦 Citations        🟥 Documents         🟩 h-index

View Scopus Profile

Featured Publications

GDF15 deficiency hinders human trophoblast invasion to mediate pregnancy loss through downregulating Smad1/5 phosphorylation
– iScience, 2023 
Reproductive effect by rheumatoid arthritis and related autoantibodies
– Review Article 
Mechanism of chromosomal mosaicism in preimplantation embryos and its effect on embryo development
– Review Article 
Strategies and challenges of mesenchymal stem cells-derived extracellular vesicles in infertility
– Review Article 
Exploring the impact of estrogenic endocrine disruptors on cervical cancer progression: A transcriptome analysis and prognostic model development
– Ecotoxicology and Environmental Safety, 2024
ZNF281 facilitates the invasion of cervical cancer cells both in vivo and in vitro
– Cancers, 2024 
Correction to: Absence of EpCAM in cervical cancer cells is involved in slug-induced epithelial–mesenchymal transition
– Cancer Cell International, 2021 

Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award | Principle Investigator | The Sixth Affiliated Hospital, Sun Yat-sen University | China 

Prof. Ping Yuan is a distinguished researcher and professor currently serving as Principal Investigator at the Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University (since January 2017), with prior appointments including Assistant Professor at the Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong (2010–2016); Postdoctoral Fellow (Stem Cell) at the Genome Institute of Singapore (2006–2010); Research Associate in Molecular Biology at Princeton University (2004–2006); and Visiting Research Fellow in Pathology at Brigham and Women’s Hospital, Boston (2001). He earned his Ph.D. from the Institute of Molecular and Cell Biology, National University of Singapore (completed 2004), after completing an M.S. in Microbiology at the Wuhan Institute of Virology, Chinese Academy of Sciences, and a B.S. from the School of Biological Sciences, Central China Normal University. Over his career, Prof. Ping Yuan has secured multiple competitive research grants — including support from the National Natural Science Foundation of China for work on YAP-associated super-enhancers in stem cells (Grant 31970674, 2020–2023), inhibition of glioblastoma stem cell proliferation (Grant 8177110391, 2018–2021), and the role of DNA repair factor Rif1 in teratocarcinoma formation (Grant 81372162, 2014–2017), as well as funding from the Research Grants Council of Hong Kong for building an in-vitro system to reconstitute female germ-lineage cells (Grant 479512, 2013–2016). His research interests center on cancer stem cells, pluripotent stem cells, epigenetic modification, and single-cell RNA sequencing (scRNA-seq), with research skills spanning molecular biology, stem cell biology, epigenetics, in vitro and in vivo functional assays, bioinformatics and genomics. Prof. Ping Yuan has contributed significantly to our understanding of how pathways such as Hippo-YAP regulate stem cell differentiation and how dysregulation may underlie cancer, particularly colorectal and other cancers. His recent work includes demonstration that interference with CAPG induces apoptosis and ferroptosis via the p53 pathway in colorectal cancer cells, and that UCKL1 plays a non-canonical role in ferroptosis defense in colorectal cancer, highlighting potential therapeutic targets. Through his sustained funding, leadership roles, and prolific output, Prof. Ping Yuan has established himself as a leading figure in the intersection of stem cell biology, epigenetics, and cancer research, influencing both basic stem cell science and translational oncology.

Profile:  scopus | ORCID 

Featured Publications

  1. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway. (2023). Molecular and Cellular Probes.

  2. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. (2023). EBioMedicine.

  3. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages. (2022). Journal for Immunotherapy of Cancer.

  4. Lin28 inhibits the differentiation from mouse embryonic stem cells to glial lineage cells through upregulation of Yap1. (2021). Stem Cells International.

  5. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. (2020). Nucleic Acids Research, 48(13), 7182–7196.

  6. CFTR constrains the differentiation from mouse embryonic stem cells to intestine lineage cells. (2019). Biochemical and Biophysical Research Communications.

  7. Differentiation of female Oct4-GFP embryonic stem cells into germ lineage cells. (2018). Cell Biology International

Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award | Professor | University of Toronto | Canada

Prof. Mingyao Liu, MD, MSc, is an internationally recognized biomedical scientist and academic leader renowned for his pioneering contributions to lung injury, transplantation immunology, and regenerative medicine. He currently serves as the James & Mary Davie Chair in Lung Injury, Repair and Regeneration at the University Health Network and as Director of the Institute of Medical Science at the University of Toronto, where he leads multidisciplinary teams advancing translational research in organ preservation and immunomodulation. Prof. Mingyao Liu obtained his M.D. and M.Sc. in Pathophysiology from the Second Military Medical University in Shanghai, China, followed by an intensive postdoctoral fellowship at the SickKids Research Institute in Toronto, Canada, where he began his journey into molecular mechanisms of lung disease and transplant biology. His professional experience spans decades of leadership roles, including Senior Scientist at the Toronto General Hospital Research Institute and Full Professor in the Department of Surgery at the University of Toronto, with cross-appointments in Medicine and Physiology. Prof. Mingyao Liu’s research interests focus on understanding ischemia-reperfusion injury, immune tolerance in organ transplantation, and cellular mechanisms driving lung regeneration. His laboratory employs advanced molecular biology, gene editing, single-cell transcriptomics, and ex vivo organ perfusion systems to identify therapeutic targets that improve graft survival and repair outcomes. His scientific expertise is further reflected through numerous publications in high-impact journals such as Transplantation, Scientific Reports, NPJ Digital Medicine, and The American Journal of Transplantation. Prof. Mingyao Liu has received multiple prestigious awards, including the Queen Elizabeth II Diamond Jubilee Medal, the Premier’s Research Excellence Award, and the Mel Silverman Mentorship Award, highlighting both his research excellence and commitment to nurturing the next generation of scientists. As a dedicated member of numerous professional societies such as the American Thoracic Society, The Transplantation Society, and the International Society of Heart and Lung Transplantation, he plays a significant role in shaping global biomedical research discourse. Prof. Mingyao Liu’s career reflects a rare combination of innovative science, effective leadership, and lifelong mentorship, making him one of the foremost authorities in lung transplant biology. His continued contributions are shaping the future of regenerative medicine through translational discoveries that bridge laboratory innovation with clinical excellence, reinforcing his position as a global leader dedicated to improving outcomes for patients with severe pulmonary diseases.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  1. Liu, M. (2025). Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft. Scientific Reports. 1 citation.

  2. Liu, M. (2025). Ischemia/Reperfusion upregulates genes related to PANoptosis in human lung transplants. Transplantation. 3 citations.

  3. Liu, M. (2025). L-Alanyl-L-Glutamine alleviated ischemia-reperfusion injury and primary graft dysfunction in rat lung transplants. Transplantation. 2 citations.

  4. Liu, M. (2025). Ex vivo delivery of recombinant IL-10 to human donor lungs. JHLT Open. 0 citations.

  5. Liu, M. (2025). Protective effects of 10 °C preservation on donor lungs with lipopolysaccharide-induced acute lung injury. Conference Proceedings. 1 citation.

  6. Liu, M. (2024). Improving prognostic accuracy in lung transplantation using unique features of isolated human lung radiographs. NPJ Digital Medicine. 3 citations.

  7. Liu, M. (2024). Ischemia-reperfusion responses in human lung transplants at the single-cell resolution. American Journal of Transplantation. 5 citations.

 

Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award 

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award | Physician | The Lower Danube University | Romania

Prof. Dr. Gabriela Gurău is an accomplished Romanian medical researcher, clinician, and academic leader with extensive contributions to the fields of clinical laboratory medicine, infectious diseases, and metabolic disorders. She holds a Ph.D. in Medical Sciences from the University of Medicine and Pharmacy “Carol Davila,” Bucharest, complemented by advanced certifications in diabetes, nutrition, metabolic diseases, and laboratory medicine from the Ministry of Health and the Training Center for Doctors and Pharmacists. Currently serving as Professor Habil. at the Faculty of Medicine and Pharmacy, University “Dunarea de Jos” of Galați, she also fulfills the role of Head of the Clinical Laboratory at the Clinical Emergency Hospital for Children “Sfântul Ioan.” Throughout her professional journey, Prof. Dr. Gabriela Gurău has demonstrated exceptional skill in integrating clinical diagnostics with translational research, focusing on pediatric infections, antibiotic resistance, microbiological profiling, and metabolic disorders. Her research interests include pathogen surveillance, microbial resistance mechanisms, pediatric metabolic health, and the interplay between microbiota and systemic diseases. With an active research portfolio, she has participated in numerous national and international projects, including innovative studies funded by PN II, AUF, and institutional grants, contributing significantly to Romania’s biomedical research landscape. She is the author and co-author of impactful peer-reviewed articles published in leading scientific journals indexed in Scopus and Web of Science, such as Life, Viruses, International Journal of Molecular Sciences, Applied Sciences, and Infection and Drug Resistance, reflecting her commitment to scientific excellence and knowledge dissemination. Her strong research skills span molecular diagnostics, laboratory analytics, data interpretation, and interdisciplinary collaboration, all of which reinforce her as a versatile scientist bridging clinical medicine and public health research. Recognized for her scholarly achievements and leadership, Prof. Dr. Gabriela Gurău has been a key figure in organizing medical conferences like MedFarmLab, served as Head of the Department of Morphological and Functional Sciences, and contributed actively to professional societies and research committees. Her dedication has earned her respect as a mentor, educator, and innovator in Romanian academia. Prof. Dr. Gabriela Gurău’s career exemplifies a synthesis of scientific rigor, community service, and academic distinction, underpinned by her mission to improve pediatric healthcare outcomes through evidence-based research. With her established reputation, international collaborations, and evolving leadership roles, Prof. Dr. Gabriela Gurău continues to advance the frontiers of laboratory medicine and inspire emerging generations of biomedical scientists worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Matache, E. R., Gurău, G., Stoian, V. I., Zaharia, A. E., Ciocoiu, M., Maftei, N. M., & Tutunaru, D. (2025). Bordetella pertussis in children: A retrospective analysis of the clinical impact and the role of vaccination. Life, 15(10), 1514.

  2. Matache, E. R., Gurău, G., Raileanu, C. R., Zaharescu, A., Popa, G. V., Maftei, N. M., & Tutunaru, D. (2025). Pathogen profile of children hospitalised with viral respiratory infections in Galati County, Romania. Viruses, 17(4), 586.

  3. Ursu, M., Cretu-Stuparu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024). An epidemiological perspective on new pediatric cases of type 1 diabetes and vitamin D deficiency in South-East Romania: A retrospective study. Children, 11(10), 1162.

  4. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Tatu, A. L. (2024). An eastern county from a European eastern country—The characteristics of cutaneous microbiome in psoriasis patients—Preliminary results. Life, 14(6), 678.

  5. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Popa, L. G. (2024). Comparative analysis of the cutaneous microbiome in psoriasis patients and healthy individuals—Insights into microbial dysbiosis: Final results. International Journal of Molecular Sciences, 25(19), 10583.

  6. Iancu, A. V., Arbune, M., Zaharia, E. A., Tutunaru, D., Maftei, N. M., Peptine, L. D., Tocu, G., & Gurău, G. (2023). Prevalence and antibiotic resistance of Enterococcus spp.: A retrospective study in hospitals of Southeast Romania. Applied Sciences, 13(6), 3866.

  7. Arbune, M., Gurău, G., Niculet, E., Iancu, A. V., Lupasteanu, G., Fotea, S., Vasile, M. C., & Tatu, A. L. (2021). Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East Romania. Infection and Drug Resistance, 14, 2369–2378.